• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  10/12/2012
Trade Name:  Bethkis
Generic Name or Proper Name (*):  tobramycin
Indications Studied:  Management of cystic fibrosis patients with P. aeruginosa
Label Changes Summary:  *Safety and efficacy have been established in adults and children 6 years and older *Safety and efficacy have not been studied in pediatric patients less than 6 years *Use caution in patients with known or suspected auditory or vestibular dysfunction or renal dysfunction. Bronchospasm can occur with inhalation of tobramycin *Information on dose, adverse reactions, and clinical trials *New drug
Product Labeling:  Labeling  Opens a new window
Sponsor:  Chiesi Pharmaceuticals, Inc.
Therapeutic Category:  Antibiotic, topical